About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID 		Sirt1
sirtuin 1
MGI:2135607
158 phenotypes from 14 alleles in 16 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background		 Annotated Term Reference
Gt(ROSA)26Sortm1(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Agrp-cre)1Gsb/0
involves: 129 * C57BL/6J * FVB/N 		normal adipose tissue phenotype J:209418
normal behavior/neurological phenotype J:209418
decreased food intake J:209418
decreased susceptibility to age related obesity J:209418
normal growth/size/body region phenotype J:209418
normal homeostasis/metabolism phenotype J:209418
increased body weight J:209418
increased food intake J:209418
increased response to leptin J:209418
Gt(ROSA)26Sortm1(Sirt1)Ktm/Gt(ROSA)26Sor+
Tg(Pomc1-cre)16Lowl/0
involves: 129 * C57BL/6J * FVB/N 		normal behavior/neurological phenotype J:209418
decreased circulating thyroxine level J:209418
decreased epididymal fat pad weight J:209418
decreased locomotor activity J:209418
decreased susceptibility to age related obesity J:209418
decreased susceptibility to induced hypothermia J:209418
decreased total body fat amount J:209418
normal growth/size/body region phenotype J:209418
normal homeostasis/metabolism phenotype J:209418
increased adipose tissue noradrenaline turnover J:209418
increased energy expenditure J:209418
increased oxygen consumption J:209418
increased response to leptin J:209418
Sirt1tm1.1Cxd/Sirt1+
either: (involves: 129S6/SvEvTac * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		exencephaly J:140089
Sirt1tm1.1Cxd/Sirt1tm1.1Cxd
either: (involves: 129S6/SvEvTac * Black Swiss * FVB/N) or (involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		abnormal cell cycle checkpoint function J:140089
abnormal cell death J:140089
abnormal chromosome morphology J:140089
abnormal DNA repair J:140089
abnormal DNA replication J:140089
abnormal head morphology J:140089
absent hindlimb buds J:140089
aneuploidy J:140089
decreased embryo size J:140089
decreased survivor rate J:140089
embryonic lethality during organogenesis, incomplete penetrance J:140089
increased cellular sensitivity to gamma-irradiation J:140089
increased cellular sensitivity to ultraviolet irradiation J:140089
increased mitotic index J:140089
lethality throughout fetal growth and development, incomplete penetrance J:140089
Sirt1tm1.1Vlcg/Sirt1tm1.1Vlcg
involves: 129S6/SvEvTac * C57BL/6NTac 		no abnormal phenotype detected J:200671
Sirt1tm1.1Ygu/Sirt1tm1.1Ygu
involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 		abnormal branching of the mammary ductal tree J:121948
abnormal mammary gland growth during pregnancy J:121948
abnormal mammary gland morphology J:121948
decreased body weight J:121948
hypolactation J:121948
neonatal lethality, incomplete penetrance J:121948
perinatal lethality, incomplete penetrance J:121948
postnatal growth retardation J:121948
postnatal lethality J:121948
normal reproductive system phenotype J:121948
Sirt1tm1.2Cxd/Sirt1tm1.2Cxd
Tg(Alb1-cre)1Dlr/?
involves: 129S6/SvEvTac * FVB/N 		hepatic steatosis J:179193
increased circulating free fatty acids level J:179193
increased circulating triglyceride level J:179193
increased liver triglyceride level J:179193
Sirt1tm1b(EUCOMM)Wtsi/Sirt1+
C57BL/6N-Sirt1tm1b(EUCOMM)Wtsi/H 		abnormal pelvic girdle bone morphology J:211773
abnormal scapula morphology J:211773
abnormal sinus arrhythmia J:211773
increased basophil cell number J:211773
Sirt1tm1b(EUCOMM)Wtsi/Sirt1tm1b(EUCOMM)Wtsi
C57BL/6N-Sirt1tm1b(EUCOMM)Wtsi/H 		abnormal iris morphology J:211773
abnormal maxilla morphology J:211773
abnormal snout morphology J:211773
abnormal tooth morphology J:211773
narrow eye opening J:211773
preweaning lethality, incomplete penetrance J:211773
Sirt1tm1Fwa/Sirt1tm1Fwa
involves: 129/Sv * 129S6/SvEvTac 		abnormal atrioventricular valve morphology J:85542
abnormal eye development J:85542
abnormal eye morphology J:85542
abnormal heart development J:85542
abnormal retina layer morphology J:85542
abnormal retina photoreceptor morphology J:85542
atrial septal defect J:85542
decreased body size J:85542
decreased embryo size J:85542
disorganized retina inner nuclear layer J:85542
disorganized retina outer nuclear layer J:85542
exencephaly J:85542
normal immune system phenotype J:85542
increased cellular sensitivity to ionizing radiation J:85542
microphthalmia J:85542
oligozoospermia J:85542
perinatal lethality, incomplete penetrance J:85542
postnatal lethality, incomplete penetrance J:85542
ventricular septal defect J:85542
Sirt1tm1Mcby/Sirt1tm1Mcby
129/Sv-Sirt1tm1Mcby 		abnormal adult Leydig cell differentiation J:146009
abnormal seminiferous tubule morphology J:146009
abnormal Sertoli cell development J:146009
abnormal spermatid morphology J:146009
abnormal spermatocyte morphology J:146009
arrest of male meiosis J:146009
arrest of spermatogenesis J:146009
decreased body size J:146009
decreased circulating follicle stimulating hormone level J:146009
decreased circulating luteinizing hormone level J:146009
decreased Leydig cell number J:146009
decreased testes secretion J:146009
increased male germ cell apoptosis J:146009
male infertility J:146009
multinucleated giant male germ cells J:146009
postnatal growth retardation J:146009
premature death J:146009
normal reproductive system phenotype J:146009
small seminiferous tubules J:146009
Sirt1tm1Mcby/Sirt1tm1Mcby
involves: 129 		abnormal digit development J:81010
decreased body weight J:81010
decreased CD8-positive, alpha-beta T cell number J:81010
decreased embryo size J:81010
exocrine pancreas atrophy J:81010
eyelids fail to open J:81010
heart right ventricle hypertrophy J:81010
interstitial pneumonia J:81010
lung inflammation J:81010
microphthalmia J:81010
perinatal lethality, incomplete penetrance J:81010
postnatal lethality, complete penetrance J:81010
pulmonary edema J:81010
short snout J:81010
Sirt1tm1Mcby/Sirt1tm1Mcby
involves: 129S1/Sv * 129X1/SvJ 		abnormal eyelid morphology J:241633
abnormal lacrimal gland morphology J:241633
abnormal palatal rugae morphology J:241633
abnormal salivary gland morphology J:241633
decreased body size J:160212, J:241633
decreased body weight J:160212
eyelids fail to open J:160212
female infertility J:160212, J:241633
hyperpnea J:241633
increased autoantibody level J:241633
lethargy J:241633
male infertility J:160212, J:241633
ocular hypotelorism J:241633
perinatal lethality J:241633
short snout J:241633
Sirt1tm1Mcby/Sirt1tm1Mcby
involves: 129S1/Sv * 129X1/SvJ * CD-1 		abnormal cellular respiration J:133127
abnormal digit development J:81010
abnormal estrous cycle J:81010
abnormal glucose tolerance J:133127
abnormal inguinal fat pad morphology J:133127
abnormal nursing J:81010
abnormal renal glomerulus morphology J:160869
abnormal seminiferous tubule epithelium morphology J:81010
abnormal sperm flagellum morphology J:81010
abnormal spermatid morphology J:81010
absent corpus luteum J:81010
absent estrous cycle J:81010
anovulation J:81010
decreased body weight J:81010
decreased brain weight J:133127
decreased CD8-positive, alpha-beta T cell number J:81010
decreased circulating thyroxine level J:133127
decreased embryo size J:81010
decreased locomotor activity J:133127
decreased testis weight J:81010
decreased urine osmolality J:160869
exocrine pancreas atrophy J:81010
eyelids fail to open J:81010
globozoospermia J:81010
glomerulonephritis J:160869
heart right ventricle hypertrophy J:81010
immotile sperm J:81010
increased anti-nuclear antigen antibody level J:160869
increased immunoglobulin level J:160869
increased insulin secretion J:133127
increased male germ cell apoptosis J:81010
increased oxygen consumption J:133127
increased urine antidiuretic hormone level J:160869
interstitial pneumonia J:81010
lung inflammation J:81010
male infertility J:81010
microphthalmia J:81010
oligozoospermia J:81010
perinatal lethality, incomplete penetrance J:81010
polydipsia J:160869
polyphagia J:133127
pulmonary edema J:81010
reduced female fertility J:81010
renal glomerular immunoglobulin deposits J:160869
short snout J:81010
slow postnatal weight gain J:133127
small ovary J:81010
teratozoospermia J:81010
thin uterus J:81010
Sirt1tm1Ygu/Sirt1tm1Ygu
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 		no abnormal phenotype detected J:121948
Sirt1tm2.1Fwa/Sirt1tm2.1Fwa
FVB.129S6-Sirt1tm2.1Fwa 		decreased body size J:162852
hypoactivity in response to feed restriction J:162852
normal mortality/aging J:162852
Sirt1tm2.1Fwa/Sirt1tm2.1Fwa
involves: 129/Sv * 129S6/SvEvTac 		abnormal eye morphology J:85542
Sirt1tm2Fwa/Sirt1tm2Fwa
involves: 129/Sv * 129S6/SvEvTac 		abnormal eye morphology J:85542
atrial septal defect J:85542
Sirt1tm3.1Mcby/Sirt1tm3.1Mcby
involves: 129/Sv * 129S1/Sv * 129S4/SvJae * 129X1/SvJ 		abnormal lacrimal gland morphology J:241633
abnormal salivary gland morphology J:241633
ocular hypotelorism J:241633
reduced male fertility J:241633
short snout J:241633
Sirt1tm3Fwa/Sirt1tm3Fwa
Tg(Nes-cre)1Kln/0
involves: 129S6/SvEvTac * C57BL/6 * SJL 		abnormal circulating hormone level J:155802
abnormal pituitary gland physiology J:155802
decreased body length J:155802
decreased body weight J:155802
decreased circulating glucose level J:155802
decreased circulating growth hormone level J:155802
decreased circulating insulin level J:155802
decreased circulating insulin-like growth factor I level J:155802
decreased pituitary gland weight J:155802
hyperactivity J:155802
impaired glucose tolerance J:155802
increased circulating prolactin level J:155802
increased insulin sensitivity J:155802
small pituitary gland J:155802
Tg(Sirt1)ASrn/?
involves: C57BL/6 * CBA 		decreased susceptibility to diet-induced hepatic steatosis J:137868
improved glucose tolerance J:137868
increased energy expenditure J:137868
increased food intake J:137868
increased susceptibility to endotoxin shock J:137868
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
11/12/2024
MGI 6.24 		The Jackson Laboratory